|
Drug Innovations 2008 Sponsors:
Allergan Inc. is a premier, global specialty pharmaceutical and medical device company that discovers, develops and commercializes innovative products for the ophthalmology, neurosciences, obesity, medical dermatology, medical aesthetic and other specialty markets.
Global headquarters are located in Irvine, California, where the company was founded in 1948. Allergan is dedicated to delivering value to its customers, satisfying unmet medical needs and improving people’s lives.
Allergan Canada is highly committed to innovation and invested roughly $11 million in research and development in 2006 alone. Allergan Worldwide boasts eight state-of-the-art manufacturing plants and four world-class research and development facilities.
For more information, visit: www.allergan.ca
AstraZeneca is a leading global pharmaceutical company with an extensive product portfolio spanning six major therapeutic areas: gastrointestinal, cardiovascular, infection, neuroscience, oncology, and respiratory. In Canada, AstraZeneca employs approximately
1,400 employees and its headquarters and packaging facilities are located in Mississauga, Ontario and a state-of-the-art drug discovery centre based in Montreal, Quebec.
For more information, visit the company’s website at www.astrazeneca.ca
At Bristol-Myers Squibb Canada, treating today's medical problems with the best-possible medications is a big part of the puzzle. Developing new innovative medicines takes years of intensive research and development. Recognized as one of the best in the industry, our pharmaceutical pipeline is how we define hope. And how we create it. Our goal is in finding effective solutions to address unmet medical needs, not only for today but, for years to come. Working towards the future, we are focused in the areas of: affective (psychiatric) disorders, Alzheimer's disease, atherosclerosis/ thrombosis, cancer, diabetes, hepatitis, HIV/AIDS, obesity, rheumatoid arthritis and related diseases, and solid organ transplant rejection. Collectively, our employees represent many cultures and backgrounds, but are bound together by the desire to extend and enhance human life.
For more information, visit the Bristol-Myers Squibb website: www.bmscanada.com
Pfizer Canada Inc. is the Canadian operation of Pfizer Inc, the world's leading pharmaceutical company. Pfizer discovers, develops, manufactures and markets prescription medicines for humans and animals. Pfizer Inc invests more than US$7 billion annually in R&D to discover and develop innovative life-saving and life-enhancing medicines in a wide range of therapeutic areas, including arthritis, cardiovascular disease, endocrinology, HIV/AIDS, infectious disease, neurological disease, oncology, ophthalmology and smoking cessation. Global headquarters are located in New York City, where the company was founded in 1849. During the Second World War, Pfizer became the first company to mass-produce penicillin, launching Pfizer into the modern pharmaceutical era. Pfizer Canada is a leader in Canadian healthcare research, investing more than $137 million in research and development activities, contributions and partnerships in 2007. The company has invested more than $1 billion in R&D since 2000. Canadian headquarters of Pfizer Global Pharmaceuticals is in Kirkland, Quebec. As one of the top corporate charitable donors in Canada, Pfizer Canada is a proud member of Imagine Canada and its Caring Company program. In 2007, Pfizer Canada's Community Investment Program supported more than 1400 non-profit organizations and projects across the country with a total investment of over $25 million.
For more information, visit:www.pfizer.ca
For more information about this event or this webpage,
contact Jennifer Hughey Assistant Editor, Conferences
This page was last updated on August 27, 2008
|
